Henry Schein/$HSIC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Henry Schein
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Ticker
$HSIC
Sector
Primary listing
Employees
25,000
Headquarters
Website
Henry Schein Metrics
BasicAdvanced
$7.5B
19.95
$3.11
0.86
-
Price and volume
Market cap
$7.5B
Beta
0.86
52-week high
$82.49
52-week low
$60.56
Average daily volume
1.5M
Financial strength
Current ratio
1.411
Quick ratio
0.595
Long term debt to equity
47.949
Total debt to equity
68.545
Interest coverage (TTM)
5.40%
Profitability
EBITDA (TTM)
998
Gross margin (TTM)
31.33%
Net profit margin (TTM)
3.05%
Operating margin (TTM)
5.70%
Effective tax rate (TTM)
24.29%
Revenue per employee (TTM)
$510,000
Management effectiveness
Return on assets (TTM)
4.53%
Return on equity (TTM)
8.12%
Valuation
Price to earnings (TTM)
19.948
Price to revenue (TTM)
0.603
Price to book
2.19
Price to tangible book (TTM)
-4.5
Price to free cash flow (TTM)
23.046
Free cash flow yield (TTM)
4.34%
Free cash flow per share (TTM)
2.692
Growth
Revenue change (TTM)
2.29%
Earnings per share change (TTM)
15.03%
3-year revenue growth (CAGR)
0.14%
10-year revenue growth (CAGR)
2.06%
3-year earnings per share growth (CAGR)
-12.54%
10-year earnings per share growth (CAGR)
1.18%
What the Analysts think about Henry Schein
Analyst ratings (Buy, Hold, Sell) for Henry Schein stock.
Bulls say / Bears say
Funds affiliated with KKR completed a $250 million strategic investment in Henry Schein, raising its ownership to 12% and adding two KKR advisors to the board to drive value-creation initiatives and governance enhancements (Business Wire).
In Q1 2025, adjusted EPS of $1.15 per share surpassed analyst estimates of $1.11, reflecting stronger profitability despite modest revenue headwinds (Reuters).
Following Q2 results, Henry Schein reaffirmed its 2025 non-GAAP EPS guidance of $4.80 to $4.94 and sales growth target of 2%–4%, underscoring management’s confidence in executing its strategic plan (Business Wire).
Henry Schein missed first-quarter 2025 revenue estimates as muted demand for dental products weighed on its top line, with Q1 sales of $3.17 billion falling short of Street forecasts of $3.23 billion (Reuters).
In Q2 2025, GAAP diluted EPS declined to $0.70 from $0.80 year-over-year and non-GAAP EPS dropped to $1.10 from $1.23, marking a 10.6% non-GAAP EPS contraction that missed prior-year levels (Business Wire).
Lower glove pricing in the U.S. distribution segment eroded gross margins in Q2, contributing to an 110 basis-point contraction in gross margin year-over-year (Business Wire).
Data summarised monthly by Lightyear AI. Last updated on 30 Sept 2025.
Henry Schein Financial Performance
Revenues and expenses
Henry Schein Earnings Performance
Company profitability
Henry Schein News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Henry Schein stock?
Henry Schein (HSIC) has a market cap of $7.5B as of October 18, 2025.
What is the P/E ratio for Henry Schein stock?
The price to earnings (P/E) ratio for Henry Schein (HSIC) stock is 19.95 as of October 18, 2025.
Does Henry Schein stock pay dividends?
No, Henry Schein (HSIC) stock does not pay dividends to its shareholders as of October 18, 2025.
When is the next Henry Schein dividend payment date?
Henry Schein (HSIC) stock does not pay dividends to its shareholders.
What is the beta indicator for Henry Schein?
Henry Schein (HSIC) has a beta rating of 0.86. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.